RecruitingNCT05276856
Recovery Rate in Secondary Hypothyroidism
Studying Central congenital hypothyroidism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Nova Scotia Health Authority
- Intervention
- Levothyroxine(drug)
- Enrollment
- 90 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2025
Study locations (1)
- Nova Scotia Health, Halifax, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05276856 on ClinicalTrials.govOther trials for Central congenital hypothyroidism
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT06452823Efficacy and Safety of Catheter Ablation of Atrial Fibrillation in Patients With Thyroid Hormone StabilizationThe Second Affiliated Hospital of Jiaxing University
- RECRUITINGNCT06083636Improvement of Laboratory Diagnostics in Hypothyroid Patients Using LevothyroxineAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- RECRUITINGNCT06728735Role of Next Generation Sequencing in the Etiological Diagnosis of Permanent Congenital Hypothyroidism With in Situ ThyroidIRCCS Azienda Ospedaliero-Universitaria di Bologna